Matrixyl 3000 and the Matrixyl Family: What to Specify
“Matrixyl” is used in the market to cover several different palmitoylated peptide actives. If you do not confirm which one you are being quoted, you cannot compare two suppliers at all.
Matrixyl is one of the most requested peptide actives in anti-ageing formulation, and one of the least precisely specified. The name is used loosely, and two suppliers quoting “Matrixyl” may not be offering the same material.
This guide covers what the name actually refers to, what to demand in writing, and how to compare quotations that look identical but are not.
Why the name alone is not enough
In the market, “Matrixyl” is applied to a family of palmitoylated peptide actives rather than a single chemical. The best-known is Matrixyl 3000, which is a blend of two palmitoylated peptides supplied in a carrier rather than a single pure powder. Other products in the family are single peptides or different blends.
The practical consequence: a quotation for “Matrixyl” tells you almost nothing until you know the composition, the concentration of active, and the carrier system.
The four things to confirm in writing
- Which peptide or blend. A single palmitoylated peptide, or a blend of two? Ask for the INCI names of every active present.
- Concentration of active. These materials are frequently supplied as a solution in a carrier, not as pure powder. The percentage of active is the number that determines your use level — and the price you should accept.
- Carrier system. Common carriers include glycerin and water-based systems. The carrier affects how the material disperses in your base and whether it suits your formulation at all.
- Preservation and shelf life. Liquid-supplied actives carry preservation and shelf-life considerations that a dry powder does not.
If the supplier cannot state all four, you are not comparing products — you are comparing labels.
Powder or solution?
| Format | Advantages | Watch for |
|---|---|---|
| Solution in carrier | Easier to incorporate; consistent dispersion | You pay for carrier; preservation and shelf life matter |
| Powder | No carrier to pay for; longer shelf life if stored correctly | Dispersion and solubilisation are your problem; weigh accurately |
Both are legitimate. What is not legitimate is comparing a solution quotation against a powder quotation as if the numbers were equivalent — they are not, because the active content differs.
How to compare two quotations properly
- Normalise to cost per gram of active, not cost per gram of material. This is the only comparison that means anything when carriers and concentrations differ.
- Ask for the COA for the exact batch, and check whether the reported figures refer to the blend or to the active.
- Confirm the use level the supplier expects in a typical formulation, and sanity-check it against your own trial.
- Ask what the material does in your pH range. Palmitoylated peptides are generally incorporated into the oil or cool-down phase depending on the carrier — confirm the supplier's recommendation rather than assuming.
- Run a small stability trial before a production order. As with any peptide active, behaviour in your specific base is what matters.
What to put in your purchase specification
A workable specification for a Matrixyl-type active should state: the INCI names of every active, the concentration of each, the carrier system, the appearance, the preservation system if liquid, the recommended use level, and the documentation to be supplied (TDS, COA, MSDS).
Write it once and send it to every supplier you approach. The quotes you get back will suddenly become comparable — and the suppliers who cannot answer it will identify themselves.
Reading a Matrixyl-type COA
The COA for a blend-based active reads differently from one for a pure powder. Two things commonly go wrong when buyers interpret it.
- The purity figure may refer to the active, not the material. A COA can report 98% purity for the peptide component while the material you receive is a solution containing a fraction of that. Read the header carefully.
- There may be no single “purity” figure at all. For a blend of two peptides in a carrier, the meaningful specification is the concentration of each active, confirmed by assay — not an area percentage.
Ask the supplier to state, in writing, which figure on the COA describes what. If that question is hard to answer, the document is not doing its job.
Carrier systems compared
| Carrier | Typical character | Considerations |
|---|---|---|
| Glycerin-based | Common for blend actives; good dispersion in water phases | Contributes humectancy to your formula; adds to the glycerin already in your base |
| Water-based | Easy to incorporate; low contribution to the base | Requires preservation; shorter shelf life than a dry powder |
| Propylene-glycol-based | Good solubilisation for some peptides | May be restricted or undesirable in some clean-beauty positionings |
| Powder | No carrier to pay for; longest shelf life if stored correctly | Solubilisation and dispersion become your problem |
The right choice follows from your product form and your claims, not from which is cheapest per gram. A glycerin carrier is a reasonable choice for a serum and a poor one for a product where you are trying to keep the humectant load low.
A purchase specification you can copy
PRODUCT: Matrixyl-type palmitoylated peptide active ACTIVE(S): [INCI name(s), all components listed] CONCENTRATION: [% of each active] CARRIER: [system, and its INCI name] APPEARANCE: [description] GRADE: Cosmetic grade — external/topical use PRESERVATION: [system, if liquid] RECOMMENDED USE LEVEL: [% w/w, as advised by supplier] DOCUMENTATION: TDS (version/date) · COA per batch · MSDS INCOTERM: [EXW / FOB / CIF] PACKAGING: [container and size] STORAGE: [conditions]
Send this to every supplier you approach. The replies will become comparable, and the suppliers who cannot complete it will identify themselves before you spend time on samples.
Worked pricing comparison
| Supplier A (solution) | Supplier B (powder) | |
|---|---|---|
| Price per kg of material | $620 | $4,800 |
| Active content | 5% (50 g active per kg) | 98% (980 g active per kg) |
| Cost per gram of active | $12.40 | $4.90 |
| Carrier you also pay for | 950 g | 20 g |
| Handling | Pour and mix | Weigh and solubilise |
The powder looks eight times more expensive per kilogram and is in fact substantially cheaper per gram of active. This is the single most common comparison error in this category — and it is entirely avoidable once you normalise the numbers.
Questions to ask before you accept a quotation
- Which peptides are in this, and at what concentration? If the answer is a trade name rather than an INCI list, ask again.
- What is the carrier, and what is its INCI name? You are declaring it in your product.
- Is the price per kilogram of material or per gram of active? Confirm which number you are being given.
- What is the recommended use level in a typical system? A supplier who has formulated has an answer.
- What documentation ships with it? TDS, batch COA and MSDS, or something less.
- What is the shelf life, and measured from when? Manufacture date or shipment date changes your planning.
- What is the minimum order for this specific product? Do not assume it matches another product's terms.
Seven questions, one email. The replies will sort the market for you.
What to expect from a sample evaluation
Once you have a sample, the evaluation is about behaviour rather than paperwork. Five observations tell you most of what you need.
| Observation | What it tells you |
|---|---|
| Ease of incorporation | Whether the carrier suits your process, and whether you need to change your order of addition |
| Appearance in the finished base | Clarity, colour and any haze that appears on standing |
| pH of the finished formula | Whether the material shifts your target, and by how much |
| Behaviour over 30 days | Whether colour, odour or viscosity change — the earliest signal of an incompatibility |
| Comparison against your current material | The only meaningful benchmark. Run both side by side in the same base |
Run the sample alongside your existing material wherever you have one. A sample evaluated in isolation tells you whether it works; a sample evaluated side by side tells you whether it is better.
Documenting the decision
When you switch or add a supplier, write down why. Not for compliance, but because in two years someone will ask why this material was chosen, and the answer is almost never recoverable from memory.
Keep the sample COA, the trial results, your purchase specification, and a short note of the comparison. It takes ten minutes and it turns a future supplier review into a reading exercise rather than a research project.
Frequently asked questions
Is Matrixyl the same as palmitoyl tripeptide-1?
Not exactly. Palmitoyl tripeptide-1 is one peptide that appears in Matrixyl-family products. The trade name covers a family, and some products are blends of more than one peptide. Confirm the INCI list for the specific material you are offered.
Why is one Matrixyl quotation so much cheaper?
Usually because it contains less active, or a different carrier, or a different peptide entirely. Compare cost per gram of active and ask for the composition in writing.
Can I buy Matrixyl in small quantities to trial?
Yes — bulk pricing typically starts at 10 g and no minimum order applies at that scale.
How do I know whether I am being quoted a blend or a single peptide?
Ask for the INCI names of every component and the concentration of each. A blend will list more than one peptide; a single active will not.
Can I substitute one Matrixyl-type product for another?
Not without reformulating and retesting. Different compositions and concentrations change the use level your formula was built around.
What is the typical use level?
It varies by product and composition. Ask the supplier for their recommendation, then confirm it with a trial batch — use level is formula-specific.
Should I buy the solution or the powder?
Solution if you want easy incorporation and consistent dispersion; powder if you want to avoid paying for carrier and want longer storage stability. Both are legitimate — the mistake is comparing their prices directly.
Does the carrier affect my claims?
It can. If you are positioning on a specific ingredient story, the carrier becomes part of the declaration and part of the story. Check what you are declaring.
How do I verify the composition on delivery?
Check the batch number against the COA, and confirm the appearance matches the specification. For a blend, the meaningful check is the assay of each active, not a single purity figure.